期刊文献+

以“运脾转枢”学术思想为指导的中西医结合治疗对慢性心力衰竭患者PTX-3、CA125的影响 被引量:2

The influence of combined treatment of traditional Chinese medicine and western medicine guided by the academic thought "transport with the spleen" on PTX-3, CA125 of patients with chronic heart failure
下载PDF
导出
摘要 目的 测定慢性心力衰竭患者血清长正五聚蛋白3(pentraxin 3,PTX-3)、血清CA125(serum carbohydrate antigen 125,CA125)的表达水平及以“运脾转枢”学术思想为指导的中西医结合治疗对其的影响.方法 将80例慢性心力衰竭患者随机分为治疗组40例和对照组40例,对照组采用常规抗慢性心力衰竭治疗,治疗在对照组常规抗心力衰竭基础上又根据中医辨证分型为:①心肾阳虚,脾阳不振,气不化水型24例;②肺失通调,脾不健运,肝郁气滞型16例.以“运脾转枢”法加减用药,观察两组治疗前后患者血清PTX-3、CA125的表达水平.结果 ①慢性心力衰竭患者血清中PTX-3、CA125水平较高,且PTX-3、CA125水平上升趋势与心功能分级呈正相关(r=0.267,P=0.002);②中西医结合治疗能显著降低慢性心力衰竭患者外周血清的PTX-3、CA125水平,治疗后治疗组PTX-3及CA125均明显降低,两组比较差异有统计学意义(P<0.05).结论 ①慢性心力衰竭患者血清PTX-3、CA125浓度与心功能分级呈正相关,可作为心衰严重程度及预后的指标;②以“运脾转枢”学术思想为指导的中西医结合治疗能显著降低患者外周血清PTX-3、CA125的表达水平,对临床治疗和预防心力衰竭进展具有重要意义,值得临床推广应用. Objective To test the levels of serum PTX-3,CA125 in patients with chronic heart failure (CHF) and discuss the influence of combined treatment of traditional Chinese medicine (TCM) and western medicine (WM) guided by the academic thought "transport with the spleen" on PTX-3,CA125.Methods 80 patients with CHF were randomly divided into treatment group and control group,40 cases in each group.Control group was treated with conventional therapy for CHF;on the basis of control group,patients in treatment group were divided into:① pattern of heart-kidney yang deficiency,spleen yang deficiency,qi failing to promote water translation (24 cases),② pattern of lung governing regulation,spleen governing regulation deficiency,liver qi depression (16 cases) according to syndrome differentiation of TCM,added and subtracted drugs according to the thought "transport with the spleen".Observed the levels of serum PTX-3,CA125 of two groups before and after treatment.Results ① The levels of serum PTX-3,CA125 in patients with CHF were high,the rising trend of the levels of serum PTX-3,CA125 was positively related with cardiac functional classification (r=0.267,P=0.002).② Combined treatment of TCM and WM significantly decreased the levels of serum PTX-3,CA125 in patients with CHF,there were statistically significant differences in the levels of serum PTX-3,CA 125 after treatment between two groups (P〈0.05).Conclusions ① The levels of serum PTX-3,CA125 in patients with CHF are positively related with cardiac functional classification,which can be used as predictive indexes of severity and prognosis of CHF.② Combined treatment of TCM and WM guided by the academic thought "transport with the spleen" can significantly decreased the levels of serum PTX-3,CA125 in patients,which takes an important part in clinical treatment and preventing the process of CHF,worthy of clinical application.
出处 《国际医药卫生导报》 2015年第14期1955-1958,共4页 International Medicine and Health Guidance News
基金 广东省2015年建设中医药强省科研课题(粤中医20152047)
关键词 运脾转枢 慢性心力衰竭 辩证论治 血清PTX-3 CA125 Transport with the spleen Chronic heart failure Dialectical treatment Pentraxin 3 Carbohydrate antigen 125
  • 相关文献

参考文献11

  • 1Benjamin J,Gregory Y.The role of monocots and inflammation in the patho physiology of heart failure[J].Eur J Heart Fail,2011,13(11):1161- 1171.
  • 2Kim J,Gozal D,Bhattacharjee R,et aI.TREM 1 and pentraxin-3 plasma levels and their association with obstructive sleep apnea,obesity,and endothelial function in children[J].Sleep,2013, 36(6):923-931.
  • 3Buyukkaya E,Karakas MF,Kurt M,et al.The serum pentraxin 3 is elevated in patients with cardiac syndrome X[J].Turk Kardiyol Dern Ars, 2013,41(4):290-295.
  • 4Davutoglu V,Yildirim C,Kucukaslan H,et al.Prognostic value of pleuraleffusion CA-125 and NT pro-BNP in patients with acute decom-pensated heart failure[J].Kardiol Pol,2010,68(7):771-778.
  • 5陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 6McMurray JJ,ADamopoulos S,Anker SD,et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association (HFA) of the ESC[J]. Eur Heart J,2012,33(14):1787-1847.
  • 7周洪彬,周绎彬,古容芳,周经彬,周新民.名老中医周炳文以运脾转枢法治疗慢性心衰经验介绍[J].新中医,2009,41(4):11-12. 被引量:32
  • 8Kotooka N, Inoue T, Aoki S, et al.Prognostic value of pentraxin3 in patients with chronic heart failure[J].Int J Gardiol,2008,130( 1 ): 19-22.
  • 9Nagele H,Bahlo M,Klapdor R et al.GA125 and its relation to car-diac function[J].Am Heart J,1999,137(6): 1044-1049.
  • 10Kouris NT, Zacharos ID, Kontogiannl DD, et al.The significance of CAl25 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiography parameters[J]. Eur J Heart Fail, 2005, 7(2):199-203.

二级参考文献1

  • 1陈灏珠,戴自英,林果为,等.实用内科学[M].12版.北京:人民卫生出版社,2005.1333—1336.

共引文献2814

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部